Who are Neuroptics's investors?

Neuroptics's investors include Aphelion Capital.

How much funding has Neuroptics raised?

Neuroptics has disclosed $1.8M raised across 3 rounds.

Where is Neuroptics headquartered?

Neuroptics is headquartered in Irvine, US.

Neuroptics

Irvine, US · Founded 1995 · 83 employees on LinkedIn · 1 known investors

Find your way into Neuroptics

NeurOptics develops pupillometry technologies for clinical decision-making in critical care, neurology, neurosurgery, and emergency medicine. The company serves medical professionals and clinical researchers globally.

Deep Tech Healthtech Medical Devices

Founders & leadership

Kamran SiminouExecutive

William WortheninPresident and Chief Executive Officer

Willam WorthenExecutive

Joseph KianiNamed on SEC filing

Board

Bob Mellen inDirectorVenture Partner at Aphelion Capital

Investors · 1

Aphelion Capital

Reported raises · per SEC filings

Form D private placements

$1.8M disclosed across 3 rounds · 2014–2016

▶$500KraisedApr 2016 · 7 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Kamran SiminouExecutive Officer, Director
Bob MellenDirector
Joseph KianiDirector
William WorthenExecutive Officer, Director

Offering amount: $500K
Amount sold: $500K
Proceeds to insiders: $25K
First sale: Apr 2016
Incorporated: Corporation, California
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$50KraisedSep 2015 · 1 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Kamran SiminouExecutive Officer, Director
Joseph KianiDirector
William WorthenExecutive Officer, Director
Bob MellenDirector

Offering amount: $600K
Amount sold: $50K
Proceeds to insiders: $60K
First sale: Aug 2015
Incorporated: Corporation, California
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.2MraisedApr 2014 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Kamran SiminouExecutive Officer, Director
Willam WorthenExecutive Officer, Director
Joseph KianiDirector

Offering amount: $2.5M
Amount sold: $1.2M
Minimum investment: $1
Proceeds to insiders: $125K
First sale: Mar 2014
Incorporated: Corporation, California
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Medscape53 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies competing with Neuroptics for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2023	$1.3M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2022	$319.1K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Neuroptics do?: NeurOptics develops pupillometry technologies for clinical decision-making in critical care, neurology, neurosurgery, and emergency medicine. The company serves medical professionals and clinical researchers globally.
Who are Neuroptics's investors?: Neuroptics's investors include Aphelion Capital.
How much funding has Neuroptics raised?: Neuroptics has disclosed $1.8M raised across 3 rounds.
Where is Neuroptics headquartered?: Neuroptics is headquartered in Irvine, US.